Xeris Pharmaceuticals Inc reported $24.24M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 8.64M 54K
Acura Pharmaceuticals ACUR:US 523K 138K
Eli Lilly And LLY:US $ 1.58B 107.8M
Endo International Ordinary Shares ENDP:US 241.92M 70.98M
Horizon Pharma HZNP:US 360.26M 5.06M
JAZZ PHA JAZZ:US 363.68M 65.35M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Perrigo Ordinary Shares PRGO:US 283.6M 11.7M
Supernus Pharmaceuticals SUPN:US $ 72.03M 2.5M
Teva Pharmaceutical Industries TEVA:US 864M 32M
Zogenix ZGNX:US $ 39.56M 5.68M